Having recently completed a comprehensive evaluation process for our organization’s application security posture, I found the comparative analysis between Apiiro and Veracode, particularly regarding their commercial models and operational efficacy, to be a complex but critical undertaking. I am sharing my structured findings here, with the hope that this detailed comparison will aid other members navigating similar procurement and technical evaluations.
The most immediate point of divergence is in their fundamental pricing architecture. Based on our vendor discussions and RFPs, I have constructed this overview:
| Pricing Dimension | Apiiro | Veracode |
| :------------------------- | :--------------------------------------------------------------------- | :------------------------------------------------------------------ |
| **Primary Model** | Annual subscription based on a **"risk platform"** scope (e.g., number of applications, code repos, DevOps tool integrations). Pricing is highly customized. | Primarily **scan-based** (per scan, with volume tiers) and **seat-based** (per developer/user). Also offers annual enterprise subscriptions. |
| **Cost Drivers** | Scale of the software supply chain (repos, pipelines), number of risk workflows, and depth of historical analysis. | Number of applications scanned, frequency of scans, and number of user licenses (for IDE, dashboard access). |
| **Initial Commitment** | Typically a more substantial enterprise engagement, with onboarding and platform integration services. | Can start with smaller, more modular commitments (e.g., scanning a set number of apps). |
This structural difference leads to a key consideration: Apiiro operates as a unified Risk Platform, weaving SAST, SCA, and secret scanning into a contextualized risk model, whereas Veracode traditionally offers these as more discrete, though well-integrated, modules (Static Analysis, Software Composition Analysis, etc.). The pricing reflects this philosophical approach.
Regarding false positive rates—a critical operational metric for team efficiency—our internal benchmarking on a representative codebase yielded notable observations:
* **Veracode SAST** demonstrated a **predictable and well-documented** false positive profile. Their taxonomy is mature, and the ability to triage findings within the platform using established policies and historical data is strong. The rate is not negligible, but the tools for managing it (including detailed path traces and suppression rules) are robust.
* **Apiiro’s SAST** engine, by contrast, presented a **lower raw volume of findings** in our tests. Crucially, their platform's context—leveraging data from the SCA, CI/CD, and issue trackers—appears to automatically suppress or de-prioritize categories of findings it deems "non-risky" based on the actual usage and exposure. This resulted in a **significantly lower effective false positive rate** presented to the developer, but it shifts the evaluation burden to trusting their risk modeling logic.
For monorepo handling, both have capabilities but with distinct operational impacts:
* Veracode requires careful configuration of scan paths and exclusions to handle large monorepos efficiently. Their incremental analysis helps, but setup is key.
* Apiiro's agentless architecture, which connects directly to version control systems, seemed to map more naturally to a monorepo's structure, automatically understanding project boundaries within the repo for more granular risk assessment.
My concluding analysis is that the choice extends far beyond a simple feature checklist. If your primary need is a rigorous, auditable, and highly controllable scanning regime with predictable costs tied directly to scan volume, Veracode's model is compelling. However, if the strategic goal is to reduce alert fatigue and developer friction by embedding risk context into every commit and pipeline stage—and you are structured for an enterprise-wide platform engagement—Apiiro's integrated approach, despite its more complex pricing, may yield a higher return on security investment through improved workflow efficiency. I am particularly interested in hearing from others who have conducted longitudinal studies on the operational overhead associated with each platform's findings triage process.
Method over hype